Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2012

01-07-2012 | Clinical Study

FABP4 is a candidate marker of cerebellar liponeurocytomas

Authors: Elena Anghileri, Marica Eoli, Rosina Paterra, Paolo Ferroli, Bianca Pollo, Valeria Cuccarini, Emanuela Maderna, Giovanni Tringali, Marco Saini, Ettore Salsano, Gaetano Finocchiaro

Published in: Journal of Neuro-Oncology | Issue 3/2012

Login to get access

Abstract

Cerebellar liponeurocytoma (cLPN) is a very rare central nervous system (CNS) tumour recently recognized as a clinical and pathological entity distinct from medulloblastoma (MB), and included in the WHO classification of CNS tumours under the heading “glioneuronal tumours”. cLPN typically develop in adult age and have a favourable prognosis compared with MB. In this work, we reviewed the clinical and neuroradiological data of two novel cases of adult cLPN diagnosed at our institution; one patient developed distant metastases. We tried to identify novel molecular markers for this malignancy. We found that the transcription factor NEUROG1 (but not ATOH1) is expressed in cLPN, unlike normal adult cerebellum, and that fatty acid binding protein 4 (FABP4), typically found in adipocytes, is significantly overexpressed compared with both normal adult cerebellum and human MB. These findings suggest cLPN occur as a result of transformation of cerebellar progenitors, which are distinct from cerebellar granule progenitors, and aberrantly differentiate into adipocyte-like tumour cells. They also suggest that analysis of FABP4 expression is of help to differentiate cLPN from MB.
Literature
1.
go back to reference Kleihues P, Chimelli L, Giangaspero F (2000) Cerebellar liponeurocytoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 110–111 Kleihues P, Chimelli L, Giangaspero F (2000) Cerebellar liponeurocytoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 110–111
2.
go back to reference Kleihues P, Chimelli L, Giangaspero F, Ohgaki H (2007) Cerebellar liponeurocytoma. In: Kleihues P, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC Press, Lyon, pp 110–112 Kleihues P, Chimelli L, Giangaspero F, Ohgaki H (2007) Cerebellar liponeurocytoma. In: Kleihues P, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC Press, Lyon, pp 110–112
3.
go back to reference Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, Markesbery WR, Ellison DW, Weller RO, Taddei GL, Conti R, Del Bigio MR, González-Cámpora R, Radhakrishnan VV, Söylemezoglu F, Uro-Coste E, Qian J, Kleihues P, Ohgaki H (2004) Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathol 14(3):281–289PubMedCrossRef Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, Markesbery WR, Ellison DW, Weller RO, Taddei GL, Conti R, Del Bigio MR, González-Cámpora R, Radhakrishnan VV, Söylemezoglu F, Uro-Coste E, Qian J, Kleihues P, Ohgaki H (2004) Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathol 14(3):281–289PubMedCrossRef
4.
go back to reference Chakraborti S, Mahadevan A, Govindan A, Yasha TC, Santosh V, Kovoor JM, Ramamurthi R, Alapatt JP, Hedge T, Shankar SK (2011) Supratentorial and cerebellar liponeurocytomas: report of four cases with review of literature. J Neurooncol 103(1):121–127PubMedCrossRef Chakraborti S, Mahadevan A, Govindan A, Yasha TC, Santosh V, Kovoor JM, Ramamurthi R, Alapatt JP, Hedge T, Shankar SK (2011) Supratentorial and cerebellar liponeurocytomas: report of four cases with review of literature. J Neurooncol 103(1):121–127PubMedCrossRef
5.
go back to reference Owler BK, Makeham JM, Shingde M, Besser M (2005) Cerebellar liponeurocytoma. J Clin Neurosci 12:326–329PubMedCrossRef Owler BK, Makeham JM, Shingde M, Besser M (2005) Cerebellar liponeurocytoma. J Clin Neurosci 12:326–329PubMedCrossRef
6.
go back to reference Buccoliero AM, Caldarella A, Bacci S, Gallina P, Taddei A, Di Lorenzo N, Romagnoli P, Taddei GL (2005) Cerebellar liponeurocytoma: morphological, immunohistochemical, and ultrastructural study of a relapsed case. Neuropathology 25(1):77–83PubMedCrossRef Buccoliero AM, Caldarella A, Bacci S, Gallina P, Taddei A, Di Lorenzo N, Romagnoli P, Taddei GL (2005) Cerebellar liponeurocytoma: morphological, immunohistochemical, and ultrastructural study of a relapsed case. Neuropathology 25(1):77–83PubMedCrossRef
7.
go back to reference Châtillon CE, Guiot MC, Roberge D, Leblanc R (2009) Cerebellar liponeurocytoma with high proliferation index: treatment options. Can J Neurol Sci 36:658–661PubMed Châtillon CE, Guiot MC, Roberge D, Leblanc R (2009) Cerebellar liponeurocytoma with high proliferation index: treatment options. Can J Neurol Sci 36:658–661PubMed
8.
go back to reference Limaiem F, Bellil S, Chelly I, Bellil K, Mekni A, Jemel H, Haouet S, Zitouna M, Kchir N (2009) Recurrent cerebellar liponeurocytoma with supratentorial extension. Can J Neurol Sci 36(5):662–665PubMed Limaiem F, Bellil S, Chelly I, Bellil K, Mekni A, Jemel H, Haouet S, Zitouna M, Kchir N (2009) Recurrent cerebellar liponeurocytoma with supratentorial extension. Can J Neurol Sci 36(5):662–665PubMed
9.
go back to reference Sharma MC, Agarwal M, Suri A, Gaikwad S, Mukhopadhyay P, Sarkar C (2002) Lipomedulloblastoma in child: a controversial entity. Human Pathol 33(5):564–569CrossRef Sharma MC, Agarwal M, Suri A, Gaikwad S, Mukhopadhyay P, Sarkar C (2002) Lipomedulloblastoma in child: a controversial entity. Human Pathol 33(5):564–569CrossRef
10.
go back to reference Aker FV, Ozkara S, Eren P, Peker O, Armagan S, Hakan T (2005) Cerebellar liponeurocytoma/lipidized medulloblastoma. J Neurooncol 71:53–59PubMedCrossRef Aker FV, Ozkara S, Eren P, Peker O, Armagan S, Hakan T (2005) Cerebellar liponeurocytoma/lipidized medulloblastoma. J Neurooncol 71:53–59PubMedCrossRef
11.
go back to reference Patel N, Fallah A, Provias J, Jha NK (2009) Cerebellar liponeurocytoma. Can J Surg 52(4):E117–E119PubMed Patel N, Fallah A, Provias J, Jha NK (2009) Cerebellar liponeurocytoma. Can J Surg 52(4):E117–E119PubMed
12.
go back to reference Hortobágyi T, Bódi L, Lantos PL (2007) Adult cerebellar liponeurocytoma with predominant pilocytic pattern and myoid differentiation. Neuropathol Appl Neurobiol 33:121–125PubMedCrossRef Hortobágyi T, Bódi L, Lantos PL (2007) Adult cerebellar liponeurocytoma with predominant pilocytic pattern and myoid differentiation. Neuropathol Appl Neurobiol 33:121–125PubMedCrossRef
13.
go back to reference Jenkinson MD, Bosma JJ, Du Plessis D, Ohgaki H, Kleihues P, Warnke P, Rainov NG (2003) Cerebellar liponeurocytoma with an unusually aggressive clinical course: case report. Neurosurgery 53(6):1425–1427PubMedCrossRef Jenkinson MD, Bosma JJ, Du Plessis D, Ohgaki H, Kleihues P, Warnke P, Rainov NG (2003) Cerebellar liponeurocytoma with an unusually aggressive clinical course: case report. Neurosurgery 53(6):1425–1427PubMedCrossRef
14.
go back to reference Gross E, Kiechle M, Arnold N (2001) Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods 47:73–81PubMedCrossRef Gross E, Kiechle M, Arnold N (2001) Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods 47:73–81PubMedCrossRef
15.
go back to reference Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773PubMedCrossRef Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773PubMedCrossRef
16.
go back to reference Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC; United Kingdom Children’s Cancer Study Group Brain Tumour Committee (2005) beta-Catenin status predicts a favourable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol 23(31): 7951–7957 Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC; United Kingdom Children’s Cancer Study Group Brain Tumour Committee (2005) beta-Catenin status predicts a favourable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol 23(31): 7951–7957
17.
go back to reference Soylemezoglu F, Soffer D, Onol B, Schwechheimer K, Kleihues P (1996) Lipomatous medulloblastoma in adults. a distinct clinicopathological entity. Am J Surg Pathol 20(4):413–418PubMedCrossRef Soylemezoglu F, Soffer D, Onol B, Schwechheimer K, Kleihues P (1996) Lipomatous medulloblastoma in adults. a distinct clinicopathological entity. Am J Surg Pathol 20(4):413–418PubMedCrossRef
18.
go back to reference Goldowitz D, Hamre K (1998) The cells and molecules that make a cerebellum. Trends Neurosci 21:375–382PubMedCrossRef Goldowitz D, Hamre K (1998) The cells and molecules that make a cerebellum. Trends Neurosci 21:375–382PubMedCrossRef
19.
go back to reference Salsano E, Croci L, Maderna E, Lupo L, Pollo B, Giordana MT, Consalez GG, Finocchiaro G (2007) Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro Oncol 9(3):298–307PubMedCrossRef Salsano E, Croci L, Maderna E, Lupo L, Pollo B, Giordana MT, Consalez GG, Finocchiaro G (2007) Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro Oncol 9(3):298–307PubMedCrossRef
20.
go back to reference Cataltepe O, Arikan MC, Ghelfi E, Karaaslan C, Ozsurekci Y, Dresser K, Li Y, Smith TW, Cataltepe S (2011) Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma. Neuropathol Appl Neurobiol. doi:10.1111/j.1365-2990.2011.01237.x Cataltepe O, Arikan MC, Ghelfi E, Karaaslan C, Ozsurekci Y, Dresser K, Li Y, Smith TW, Cataltepe S (2011) Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma. Neuropathol Appl Neurobiol. doi:10.​1111/​j.​1365-2990.​2011.​01237.​x
21.
go back to reference Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J (official publication of the Federation of American Societies for Experimental Biology) 23:3865–3873CrossRef Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J (official publication of the Federation of American Societies for Experimental Biology) 23:3865–3873CrossRef
22.
go back to reference Kawai M, Rosen CJ (2010) PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6(11):629–636PubMedCrossRef Kawai M, Rosen CJ (2010) PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6(11):629–636PubMedCrossRef
23.
go back to reference Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ (2011) A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med 17(5):623–626PubMedCrossRef Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ (2011) A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med 17(5):623–626PubMedCrossRef
24.
go back to reference Urbanska K, Pannizzo P, Grabacka M, Croul S, del Valle L, Khalili K, Reiss K (2008) Activation of PPARα inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer 123:1015–1024PubMedCrossRef Urbanska K, Pannizzo P, Grabacka M, Croul S, del Valle L, Khalili K, Reiss K (2008) Activation of PPARα inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer 123:1015–1024PubMedCrossRef
Metadata
Title
FABP4 is a candidate marker of cerebellar liponeurocytomas
Authors
Elena Anghileri
Marica Eoli
Rosina Paterra
Paolo Ferroli
Bianca Pollo
Valeria Cuccarini
Emanuela Maderna
Giovanni Tringali
Marco Saini
Ettore Salsano
Gaetano Finocchiaro
Publication date
01-07-2012
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2012
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-0853-0

Other articles of this Issue 3/2012

Journal of Neuro-Oncology 3/2012 Go to the issue